Target specific optimization of cationic lipid-based systems for pulmonary gene therapy

D Deshpande1, P Blezinger, R Pillai

  • 1GENEMEDICINE, INC., The Woodlands, Texas 77381-4248, USA. deshpd@genemedicine.com

Pharmaceutical Research
|October 2, 1998
PubMed
Summary

Formulation variables significantly impact cationic lipid-mediated gene delivery to the lungs. Optimizing lipid structure, DNA ratio, particle size, and plasmid topology enhances transgene expression and DNA stability in pulmonary tissues.